Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Total Current Liabilities (2016 - 2025)

Option Care Health (OPCH) has disclosed Total Current Liabilities for 17 consecutive years, with $829.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Current Liabilities rose 6.31% year-over-year to $829.3 million, compared with a TTM value of $829.3 million through Dec 2025, up 6.31%, and an annual FY2025 reading of $829.3 million, up 6.31% over the prior year.
  • Total Current Liabilities was $829.3 million for Q4 2025 at Option Care Health, up from $823.9 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $829.3 million in Q4 2025 and bottomed at $420.2 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $629.3 million, with a median of $621.3 million recorded in 2023.
  • Peak annual rise in Total Current Liabilities hit 26.17% in 2024, while the deepest fall reached 2.97% in 2024.
  • Year by year, Total Current Liabilities stood at $459.7 million in 2021, then rose by 22.98% to $565.4 million in 2022, then rose by 9.37% to $618.3 million in 2023, then grew by 26.17% to $780.1 million in 2024, then rose by 6.31% to $829.3 million in 2025.
  • Business Quant data shows Total Current Liabilities for OPCH at $829.3 million in Q4 2025, $823.9 million in Q3 2025, and $773.6 million in Q2 2025.